Healthcare costs, insurance barriers, and medical debt are preventing patients with chronic illnesses in the US from ...

White G. Rethinking Your C&GT Value Chain: How to Ensure Readiness for Evolving Specialized Therapy Requirements. April 9, ...

Steffen Lang, president, operations, executive committee member, Novartis, shares strategic insights on how pharma supply chain leaders can elevate operations to drive innovation, growth, and patient ...

Respective industry and government agendas could significantly reshape the US prescription drug market.

“To move at speed, you need to partner with people that are better than you.” This was just one of several memorable quotes ...

A panel discussion breaks down ways for stakeholders to meet temperature-controlled operational demands pertaining to product ...

In the second part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Rachel Thorpe, executive director at ...

Ensuring that essential treatments reach patients safely and efficiently is an increasing imperative in today's pharma landscape.

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Chris O’Dell, Turquoise Health’s SVP of market solutions, outlines the key provisions of the recently released ...

Steffen Lang, president, operations, executive committee member, Novartis, discusses the premise of a keynote session on reimagining operations.

In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Colin Banas, MD, DrFirst’s chief medical officer, shares his thoughts on the rumors that RFK Jr. could ...

New facility is expected to serve as a global hub for accelerating the development of next-generation antibody-drug ...